Clinical Trials Browser

Phase 1/2 × HER-2 Positive Breast Cancer × eribulin × Clear all

NCT01388647 2015-08-28

Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer

Phase 1/2 Terminated

12 enrolled 12 charts

HER-2 Positive Breast Cancer